Summary & Overview
CPT 88302: Surgical Pathology, Level II Tissue Examination
CPT code 88302 represents Level II surgical pathology, encompassing both gross and microscopic examination of tissue specimens. This procedure is a cornerstone in diagnostic medicine, enabling pathologists to identify and characterize disease processes through detailed tissue analysis. The code is widely recognized and reimbursed by major national payers, including Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare, underscoring its clinical and financial significance across the healthcare landscape.
This publication provides a comprehensive overview of CPT code 88302, including payer coverage, clinical context, and its role within the broader spectrum of surgical pathology codes. Readers will gain insights into typical laboratory settings where this service is performed, common billing practices, and relevant policy updates. The analysis also highlights associated taxonomies and ICD-10 diagnoses frequently linked to this code, offering a clear understanding of its application in patient care. Additionally, comparisons to related surgical pathology codes are presented to contextualize the level of complexity and scope of services provided under 88302. This resource is designed to inform healthcare professionals, billing specialists, and policy stakeholders about current benchmarks and regulatory considerations for surgical pathology services.
CPT Code Overview
CPT code 88302 is used for Level II surgical pathology services, specifically for the gross and microscopic examination of tissue specimens. This code is classified under the Pathology service type and is typically performed in a laboratory setting, designated as Place of Service 81. The procedure involves the evaluation of tissue samples to assist in the diagnosis and management of various medical conditions, providing essential information for clinical decision-making.
Clinical & Coding Specifications
Clinical Context
A patient presents with a skin lesion, mass, or swelling that requires further evaluation to determine its nature. The clinician performs a biopsy or excision of the tissue and submits the specimen to the laboratory. In the laboratory (Place of Service 81), a pathologist conducts a Level II surgical pathology examination, which includes both gross and microscopic analysis of the specimen. This process helps to identify whether the lesion is benign, malignant, or of uncertain behavior, guiding further clinical management.
Coding Specifications
-
Modifiers:
-
Modifier
26: Used when reporting only the professional component of the pathology service (interpretation by the pathologist). -
Modifier
TC: Used when reporting only the technical component (preparation and processing of the specimen in the laboratory).
-
-
Provider Taxonomies:
Taxonomy Code Specialty Name 207ZP0102XAnatomic Pathology & Clinical Pathology 207ZP0101XCytopathology 207ZP0104XForensic Pathology
These taxonomies represent specialties qualified to perform and interpret surgical pathology procedures.
Related Diagnoses
-
D49.2- Neoplasm of unspecified behavior of bone, soft tissue, and skin- Relevant when the nature of a neoplasm is unclear and requires pathology examination to determine its behavior.
-
C44.99- Other specified malignant neoplasm of skin- Used when a skin lesion is suspected to be malignant and surgical pathology is needed for confirmation.
-
D48.5- Neoplasm of uncertain behavior of skin- Applied when a skin lesion's behavior is uncertain, necessitating microscopic evaluation.
-
L98.9- Disorder of the skin and subcutaneous tissue, unspecified- Used for non-specific skin disorders where pathology may help clarify the diagnosis.
-
R22.9- Localized swelling, mass and lump, unspecified- Indicates a mass or lump of unknown origin, for which surgical pathology can provide diagnostic information.
Related CPT Codes
-
88304- Level III - Surgical pathology, gross and microscopic examination- Used for specimens requiring a higher level of complexity than Level II, often for more involved tissue types.
-
88305- Level IV - Surgical pathology, gross and microscopic examination- Commonly used for routine biopsies and excisions, representing a standard level of complexity.
-
88307- Level V - Surgical pathology, gross and microscopic examination- Applied to specimens with significant complexity, such as major organs or deep tissue.
-
88309- Level VI - Surgical pathology, gross and microscopic examination- Reserved for the most complex specimens, such as radical resections or extensive tissue analysis.
These codes are related to 88302 as they represent increasing levels of complexity in surgical pathology. Depending on the specimen type and clinical scenario, one of these codes may be used as an alternative to 88302. They are not typically billed together for the same specimen, but may be used in sequence for different specimens from the same patient encounter.
National Reimbursement Benchmarks
Nationally, the mean rate for CPT code 88302 is highest with Blue Cross Blue Shield at $28.10, while Medicare's mean rate is $22.53. The average commercial mean rate, represented by BUCA, is $24.73, which is moderately higher than Medicare.
Rate dispersion, measured by the difference between the 75th and 25th percentiles, varies across payers. Blue Cross Blue Shield shows the widest spread at $17.70, indicating greater variability in rates. Cigna also has a wide dispersion at $20.50. In contrast, Aetna and UnitedHealth Group have tighter ranges, with dispersions of $11.67 and $13.00, respectively. Medicare's range is $25.00, reflecting significant variability.
The table and chart below present a detailed breakdown of national benchmarks for each payer, including mean rates and percentile values.
State Benchmarks
State: AK1 / 51
Alaska Benchmarks
Alaska exhibits a wide rate spread for CPT code 88302, with Blue Cross Blue Shield showing a difference of $30.00 between the 75th and 25th percentiles, and Medicare displaying an even larger spread of $23.00. Aetna's rates are tightly clustered, with all percentiles at $84.33, indicating little variation. Compared to national averages, Alaska's commercial payers, especially Aetna and Blue Cross Blue Shield, reimburse at substantially higher rates, often more than double or triple their national mean values. Medicare's mean rate in Alaska is slightly below the national average, but its percentile spread is similar.
The table and chart below present the full breakdown of mean and percentile reimbursement rates for each payer in Alaska, highlighting the significant differences across payers and the elevated commercial rates relative to national benchmarks.
Key Insights for Alaska
- Aetna is the highest paying payer for CPT 88302 in Alaska, with a mean rate of $80.62.
- Medicare is the lowest paying payer, with a mean rate of $21.61, closely followed by Cigna Health at $23.31.
- All commercial payers in Alaska reimburse at rates significantly above their respective national averages, with Aetna's mean rate more than triple the national mean.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.